Regardless of the SP, this company has to be one of the most interesting on the ASX. It could end up in the gutter or a block buster, I don't really know which.
The history of its journey so far is the type of thing the should be taught in senior school business classes.
The lessons in investor psychology alone have been invaluable, if only we could be privy to the boardroom dealings when it comes to financing the company. I think there would be plenty of lessons to be learnt there. History suggests that the board will pull another rabbit out of the hat to live another day.
Ann: Update on Novartis Agreement, page-210
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.065(4.73%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.46 | $1.38 | $4.077M | 2.888M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 11814 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.44 | 18125 | 14 |
View Market Depth
| Last trade - 13.38pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |